The loss of pRB expression may also be the result of mutation or microdeletion of the RB1 promoter region, as described in hereditary retinoblastoma and prostate cancer (Bookstein et al, 1990a; Sakai et al, 1991). Here, RB1 is linked to prostate cancer.